DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Clovis Oncology, Inc. (CLVS)
« Back to company indexCLVS Chatter Timeline
Stock Ticker for CLVS
Most Active Tweeters for CLVS
| User | Tweets |
|---|---|
| @Gambiste1 | 7 |
| @Tickeron | 4 |
| @dellakwal | 4 |
| @JDR1024 | 4 |
| @ConsumerFeed | 3 |
Recent Tweets for CLVS
 |
@dellakwal added shares at 5.30 today $CLVS 1:09pm |
 |
@MasterTraderAle $CLVS decent size buys crossing 1:09pm |
|
@MasterTraderAle $CLVS 5.30s is bottom. See ya at $7s when the news out 11:09am |
 |
@Gambiste1 RT @sunrgu: $CLVS short interest almost 21 million shares 12:09am |
 |
@sunrgu $CLVS short interest almost 21 million shares September 15th 2019, 9:09pm |
 |
@AmericanBanking Clovis Oncology $CLVS Given Average Rating of “Hold” by Brokerages https://t.co/86UwM57zpy #stocks September 15th 2019, 10:09am |
 |
@WeekHerald Clovis Oncology $CLVS Given Average Rating of “Hold” by Brokerages https://t.co/lnlXXB0Wny September 15th 2019, 10:09am |
 |
@OlympiaReport Clovis Oncology $CLVS Given Average Rating of “Hold” by Brokerages https://t.co/TKLz8moxZ7 September 15th 2019, 10:09am |
 |
@dispatchtribune Clovis Oncology $CLVS Given Average Rating of “Hold” by Brokerages https://t.co/qv5fFzPTuN September 15th 2019, 10:09am |
|
@dispatchtribune Clovis Oncology $CLVS Trading Down 5.3% https://t.co/phTmm3gUXH September 14th 2019, 12:09pm |
|
@OlympiaReport Clovis Oncology $CLVS Trading Down 5.3% https://t.co/Yze6P8Q3ds September 14th 2019, 12:09pm |
 |
@Tickeron $CLVS's price moved below its 50-day Moving Average on March 22, 2019. View odds for this and other indicators:… https://t.co/gu5cZhLmXS September 14th 2019, 5:09am |
 |
@bbnsnews $36.31 Million in Sales Expected for Clovis Oncology $CLVS This Quarter https://t.co/FJJYIKtNoa September 14th 2019, 2:09am |
|
@OlympiaReport Zacks: Analysts Expect Clovis Oncology $CLVS Will Announce Earnings of -$1.87 Per Share https://t.co/btRbtmPtF7 September 14th 2019, 2:09am |
 |
@ConsumerFeed Zacks: Analysts Expect Clovis Oncology $CLVS Will Announce Earnings of -$1.87 Per Share https://t.co/dNO774nUZo September 14th 2019, 2:09am |
|
@Gambiste1 RT @TrendSpider: $CLVS Why waiting for a successful retest + go is important when trading down-channel breakouts... BTW this is a weekly ch… September 14th 2019, 1:09am |
 |
@TrendSpider $CLVS Why waiting for a successful retest + go is important when trading down-channel breakouts... BTW this is a we… https://t.co/A4EHP0w8Sq September 13th 2019, 11:09pm |
|
@sunrgu @semodough BMY can buy $CLVS for cheap and can get good ROI September 13th 2019, 7:09pm |
|
@Tickeron $CLVS in Downtrend: 50-day Moving Average crossed below 200-day Moving Average on December 15, 2017. View odds for… https://t.co/JtYvAbIar6 September 13th 2019, 2:09am |
 |
@ShafferBiotech @MSollender $CLVS comes to mind September 12th 2019, 3:09pm |
|
@Gambiste1 RT @MaxD56808233: great news from $CLVS #ProstateCancerAwarenessMonth #ovariancancer Clovis Oncology to Highlight Expanded Data from Rubra… September 12th 2019, 12:09pm |
|
@dellakwal added a little more of $CLVS September 12th 2019, 11:09am |
 |
@MaxD56808233 great news from $CLVS #ProstateCancerAwarenessMonth #ovariancancer Clovis Oncology to Highlight Expanded Data from… https://t.co/HKuJFc3Wek September 12th 2019, 9:09am |
|
@Gambiste1 RT @JDR1024: @grassosteve Been some insider buying going on in an old friend of yours, $CLVS. September 12th 2019, 8:09am |
|
@Gambiste1 RT @JDR1024: @ACInvestorBlog Giddy up, $CLVS! September 12th 2019, 8:09am |
 |
@JDR1024 @grassosteve Been some insider buying going on in an old friend of yours, $CLVS. September 12th 2019, 8:09am |
|
@JDR1024 @ACInvestorBlog Giddy up, $CLVS! September 12th 2019, 8:09am |
|
@dellakwal Clovis Oncology to Highlight Expanded Data from Rubraca® (rucaparib) TRITON and ARIEL Clinical Pr... $clvs… https://t.co/b0LpN3SOdW September 12th 2019, 5:09am |
 |
@newswithvalue $CLVS: (rucaparib) TRITON and ARIEL Clinical Programs in Prostate and …: https://t.co/RsjdJ0Brw9 September 12th 2019, 4:09am |
|
@Tickeron $CLVS in Downtrend: 50-day Moving Average moved below 200-day Moving Average on December 15, 2017. View odds for th… https://t.co/J34lZi5hJI September 12th 2019, 3:09am |
|
@Gambiste1 RT @semodough: Sept. 29 – $CLVS – Rubraca (prostate cancer) Phase II data Updated TRITON2 trial data for Rubraca in mCRPC will be presented… September 11th 2019, 9:09pm |
|
@ConsumerFeed Analysts Expect Clovis Oncology $CLVS Will Post Quarterly Sales of $36.31 Million https://t.co/hFACaR7P8Z September 11th 2019, 9:09pm |
|
@AmericanBanking RegeneRx Biopharmaceuticals $RGRX versus Clovis Oncology $CLVS Financial Analysis https://t.co/tqJaVa0rAL #stocks September 11th 2019, 4:09pm |
|
@ConsumerFeed Clovis Oncology $CLVS vs. RegeneRx Biopharmaceuticals $RGRX Critical Analysis https://t.co/EUlQJjteHl September 11th 2019, 4:09pm |
|
@JDR1024 @ACInvestorBlog $CLVS under accumulation. More insider buys at $RKDA! September 11th 2019, 3:09pm |
 |
@MyFriendFate $CLVS nice strength. I've got a big position at 5.95 September 11th 2019, 3:09pm |
|
@JDR1024 @ACInvestorBlog $CLVS great price action yesterday with volume. Ready to break higher imo. September 11th 2019, 2:09pm |
|
@dellakwal bought 1k shares of $CLVS down 83% worse case goes to zero best case gets taken out if pipeline works . September 11th 2019, 2:09pm |
 |
@WhispererLoan RT @ACInvestorBlog: $CLVS on my swing long list. Breakout watch over 6.16 https://t.co/AJQ68pkLLq September 11th 2019, 7:09am |
 |
@ACInvestorBlog $CLVS on my swing long list. Breakout watch over 6.16 https://t.co/AJQ68pkLLq September 11th 2019, 7:09am |
|
@Tickeron $CLVS in Downtrend: 50-day Moving Average broke below 200-day Moving Average on December 15, 2017. View odds for th… https://t.co/fs6JJuHCbn September 11th 2019, 3:09am |
 |
@dailypoliticaln Clovis Oncology $CLVS Shares Up 13.4% https://t.co/Pgo8G3K9JX September 10th 2019, 11:09pm |
 |
@ZolmaxNews Clovis Oncology $CLVS Shares Up 13.4% https://t.co/ScnHGWyaqw September 10th 2019, 11:09pm |
 |
@semodough Sept. 29 – $CLVS – Rubraca (prostate cancer) Phase II data Updated TRITON2 trial data for Rubraca in mCRPC will be… https://t.co/m7O2SWglFY September 10th 2019, 9:09pm |
 |
@BuyWrites Good day in the markets for me today. Oncology stocks $PBYI and $CLVS way up on no obvious news. September 10th 2019, 5:09pm |
|
@Gambiste1 RT @biotechw2019: $CLVS a pincher continuation with SAR flipped ! 20 DMA support. open gap $8 https://t.co/cmfPqLvAZG September 10th 2019, 5:09pm |
 |
@danielccross Time for $CLVS to raise again?? September 10th 2019, 4:09pm |
 |
@biotechw2019 $CLVS a pincher continuation with SAR flipped ! 20 DMA support. open gap $8 https://t.co/cmfPqLvAZG September 10th 2019, 3:09pm |
 |
@Stock_News_Now $CLVS: New SEC Filing for CLVS: Form SC 13G/A (No. 0001144204-19-044100): https://t.co/xcbL4LsaWT September 10th 2019, 3:09pm |
 |
@confcalltran The Vanguard Group just provided an update on share ownership of Clovis Oncology https://t.co/clmbluj4pE $CLVS September 10th 2019, 3:09pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.